Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments.
Clin Transl Radiat Oncol
; 38: 161-168, 2023 Jan.
Article
em En
| MEDLINE
| ID: mdl-36466748
APBI, accelerated partial breast irradiation; ART; ART, adaptive radiotherapy; BED, biologically equivalent dose; CAGR, compound annual growth rate; CBCT, cone beam computerized tomography; Care patterns; GDPR, General Data Protection Regulation; Gy, gray; H&N, head and neck; HIPAA, Health Insurance Portability and Accountability Act; IGRT, image-guided radiation therapy; MR, magnetic resonance; MR-IGRT; MRI, magnetic resonance imaging; MRI-guided radiotherapy; MRIdian, 0.35Tesla(T)-MRgRT; MRgRT, magnetic resonance-guided radiotherapy; MVCT, mega-voltage CT; NSCLC, non-small cell lung cancer; OAR, organs at risk; On-table adaptive radiation therapy; PHI, protected health information; PTV, planning target volume; RT, radiation therapy; SABR, stereotactic ablative radiation therapy; SBRT; SBRT, stereotactic body radiotherapy; Stereotactic body radiotherapy; T, Tesla; UHfx, ultra-hypofractionated; linac, linear accelerator; oART; oART, on-table adaptive radiation therapy
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Clin Transl Radiat Oncol
Ano de publicação:
2023
Tipo de documento:
Article